SAN FRANCISCO, May 24, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in Sunrun Inc. (NASDAQ:RUN) of the July 3, 2017 Lead Plaintiff deadline in the pending securities class action.
If you purchased or otherwise acquired securities of Sunrun between September 10, 2015 and May 3, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On May 3, 2017, The Wall Street Journal reported that the SEC is investigating whether solar energy companies are masking how many customers they are losing.
More specifically, it reported the SEC is investigating Sunrun disclosures of how many customers have canceled contracts after signing up for a home solar energy system. Moreover, according to the article “[t]he SEC recently issued a subpoena to Sunrun and interviewed current and former employees about the adequacy of its disclosures on account cancellations.”
In response to this news, the price of Sunrun shares fell over 8% on May 3, 2017.
Recently, on May 23, 2017, The Wall Street Journal reported that former managers “say they manipulated a key sales metric around the time of the company’s August 2015 initial public offering” and “[t]he former managers of Sunrun Inc. say they were told by their superiors to hold off on internally reporting hundreds of customers who canceled their contracts during a roughly five-month period in the middle of 2015.”
According to the Journal, “Sunrun’s cancellation data influenced at least two of the company’s key financial metrics: its number of customers and its amount of ‘megawatts booked,’ which describes the amount of energy production generated by home energy systems sold to customers.”
“The customer cancellation rate is an important metric for investors when they consider whether to purchase shares, so Sunrun should be accurate and transparent about that number,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Sunrun should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 



